Passive protection?

From a few human cases on the east coast in 2001, the West Nile virus rapidly spread west in 2002, the year represented in this map. Credit: Redrawn from CDC Map" />From a few human cases on the east coast in 2001, the West Nile virus rapidly spread west in 2002, the year represented in this map. Credit: Redrawn from CDC Map Eight years ago, a mysterious virus hit New York City. It caused encephalitis in eight patients at Flushing Hospital in Queens, who all lived within a two-mile ra

Written byEdyta Zielinska
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Eight years ago, a mysterious virus hit New York City. It caused encephalitis in eight patients at Flushing Hospital in Queens, who all lived within a two-mile radius of each other. After some confusion about the origin of the virus, researchers soon realized that these were, in fact, the first reported cases of West Nile virus (WNV) in North America.

In the following years, the virus rapidly spread west, with human infections following in areas where animal infections were reported the year before. In 2002, the epidemic soared to 4,156 cases nationwide, from a mere 66 the year before. Reports started to come in of infections that were spread by blood transfusions from subclinically infected people. Baxter Scientific, a healthcare products company, conducted a study to ensure that its plasma products weren't also contaminated with WNV.

Thomas Kreil and his colleagues at Baxter led that study and gathered the intravenous ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies